Please cite this article in press as: Baker MM, et al. Validated spectrophotometric and chromatographic methods for
analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir. Ann Pharm Fr (2017),
http://dx.doi.org/10.1016/j.pharma.2017.07.005
ARTICLE IN PRESS
+Model
PHARMA-520; No. of Pages 16
Annales Pharmaceutiques Françaises (2017) xxx, xxx—xxx
Disponible en ligne sur
ScienceDirect
www.sciencedirect.com
ORIGINAL ARTICLE
Validated spectrophotometric and
chromatographic methods for analysis of
the recently approved hepatitis C antiviral
combination ledipasvir and sofosbuvir
Méthodes spectrophotométriques et chromatographiques validées pour
l’analyse de la combinaison antivirale de l’hépatite C récemment approuvée,
le ledipasvir et le sofosbuvir
M.M. Baker
a
, D.S. El-Kafrawy
b
, M.S. Mahrous
b
,
T.S. Belal
c,*
a
Methodology Department, Pharco Pharmaceuticals Company, Alexandria, Egypt
b
Pharmaceutical Chemistry Department, Faculty of Pharmacy, University of Alexandria,
Elmessalah 21521, Alexandria, Egypt
c
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, University of
Alexandria, Elmessalah 21521, Alexandria, Egypt
Received 13 May 2017; accepted 24 July 2017
KEYWORDS
Ledipasvir;
Sofosbuvir;
Derivative
spectrophotometry;
Ratio spectra;
HPTLC;
HPLC-DAD
Summary This work describes five simple and reliable spectrophotometric and chromato-
graphic methods for analysis of hepatitis C antiviral binary mixture of ledipasvir (LPV) and
sofosbuvir (SBV). Method I is based on the use of A
max
and derivative spectrophotometry with
the zero-crossing technique where LPV was determined using its A
max
and
1
D amplitudes at 324
and 338 nm respectively, while SBV was determined by measuring the
1
D amplitudes at 276 nm.
Method II involves the application of the ratio spectra derivative spectrophotometry. For LPV,
12 g/mL SBV was used as divisor and the
1
DD amplitudes at 239.8 nm were plotted against LPV
concentrations; while by using 10 g/mL LPV, the amplitudes at 279.2 nm were found propor-
tional to SBV concentrations. Method III depends on ratio-difference measurement where the
∗
Corresponding author.
E-mail address: tbelaleg@yahoo.com (T.S. Belal).
http://dx.doi.org/10.1016/j.pharma.2017.07.005
0003-4509/© 2017 Acad´ emie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.